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Abstract  
Background Laparoscopic sleeve gastrectomy (LSG) has become more popular in recent 
years. The aim of this study was to determine the vitamin and mineral status in patients up to 
5 years after LSG, and to explore changes that occurred from preoperatively to 1, 2 and 5 
years after surgery.   
Methods Data reviewed included age, sex, weight and body mass index (BMI), micronutrient 
supplements consumed and blood levels of 25 hydroxyvitamin D (25 (OH)D), PTH 
(parathyroid hormone), ferritin, haemoglobin, folate and vitamin B12, prior to and post-LSG. 
Data was collated from medical records of morbidly obese patients who had undergone LSG 
surgery.  
Results  There were a maximum of 336 patients with preoperative and 1 year after surgery 
values, n=272 for 2 years and n=116 for 5 years after surgery. At 5 years only 54% (58/107) 
of patients reported taking daily multivitamin supplements.  While most patients had values 
within the reference range for haemoglobin, vitamin B12, folate and vitamin D five years 
after LSG, 36 % (34/94) of the patients had serum ferritin below reference value.  
Conclusion This study has highlighted a low micronutrient supplementation adherence. 
Ferritin levels decreased over time even with multivitamin supplementation. To improve 
micronutrient guidelines prior to and after LSG more research, including controlled 
supplementation studies are necessary.  
 
Keywords Sleeve gastrectomy - Micronutrient status - Vitamin D - Multivitamins  
INTRODUCTION 
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Bariatric surgery is the only evidence-based long-term treatment option that has shown 
sustained weight loss and improvement in comorbidities (1). Additional to lowering body 
weight, bariatric surgery has beneficial effects on type 2 diabetes, blood pressure, 
hyperlipidimia, stroke and cardiovascular events (2-4). Furthermore, patients after bariatric 
surgery have a significant reduced mortality compared with controls (5, 6).  
The Laparoscopic sleeve gastrectomy (LSG) procedure has become highly popular in recent 
years and the number of procedures has increased in Europe and in the United States (7). 
However, as a relative newcomer there is a paucity of research investigating the incidence of 
micronutrient status after LSG.  
Morbidly obese patients have high occurrence of micronutrient deficiencies compared with 
healthy weight individuals of same sex and age (7). These deficiencies might be important to 
detect prior to surgery as these can deteriorate postoperatively and may result into long-term 
complications (8).  
Recent studies conducted up to 2016 have identified a high occurrence of vitamin D (25 (OH) 
D) deficiencies in patients prior to bariatric surgery. Folate, vitamin B12 and iron levels have 
also been frequently reported to be low in patients prior to LSG (7-13). Studies investigating 
anaemia and micronutrient deficiencies in patients after LSG are limited. Vitamin deficiencies 
are of concern after bariatric surgery, with 50% of reported deficiencies occurring within the 
first year of surgery (9).  The LSG surgery does not seem to affect the digestive system 
besides from accelerating the gastric emptying and possibly from consequences due to 
resection of the gastric fundus (14, 15). However, there is still lack of evidence on how LSG 
affects the gastric emptying and if fast passage of food though the gastrointestinal tract 
promotes micronutrient deficiencies (14). Removing the gastric fundus during LSG decreases 
the production of parietal cells that secrets hydrochloric acid which can affect iron absorption 
and intrinsic factor (IF) that is essential for vitamin B12 uptake (8, 16). Recent studies have 
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shown that low levels of vitamin B12 and iron are common in patients 1 to 3 years post-LSG 
(7-9, 11, 17, 18). LSG patients are also at risk of low levels of folate, 25 (OH) D, and ferritin 
postoperatively (7, 9, 10, 12, 17, 19). Studies investigating long-term micronutrient 
deficiencies after LSG are few and to our knowledge only a small study (n=30 at 5 years) by 
Saif et al. (2012) is the only publication that has reported micronutrient deficiencies after LSG 
with a five-year follow-up(19).  Hence, there are still uncertainties on which micronutrient 
deficiencies present in these patients and whether specific micronutrient supplementation is 
required.  
 
The aim of this study was therefore to determine the vitamin and mineral status in patients up 
to five years after LSG, and to explore changes that occurred from preoperatively to one, two 
and five years after surgery. In this study we focus on vitamin B12, folate, 25 (OH)D and 
iron. 
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MATERIALS AND METHODS 
Data was extracted from the database for bariatric surgery at Førde Central Hospital. This is a 
database approved by the Norwegian Data Inspectorate and patient inclusion is based on 
written informed consent allowing data to be used for surveillance and research. Exclusion 
criteria for surgery included pregnancy and active psychosis.  Patients included in this study 
were operated in the time period between May 2007 and April 2014.   
Patients eligibility for LSG was based on international standard criteria for bariatric 
surgery(20). Systematic follow-up examinations were scheduled at 12, 24 and 60 months after 
surgery. At every follow-up time, anthropometric measurements and biomaterial sampling 
were completed. Inclusion criteria for the study was at least one preoperative blood sample 
and one during the first post-operative year.  
Surgical procedure 
Prior to surgery, patients were offered a one-day seminar which included information from a 
clinical nutritionist, nurse, surgeon, psychologist and a previously operated patient. 
Estimations of results and information about life changes after surgery as nutrition, smoking 
and physical activity was provided. A detailed description on how the LSG operation 
procedure was conducted on the patients at Førde Central Hospita has been published(12). 
Post- surgery all patients were advised to consume a low carbohydrate diet, high protein diet, 
high frequency of water, a multivitamin tablet daily and include physical activity. The first 61 
patients were routinely recommended to take Calcigran Forte (NycoMed Pharma TM) post- 
surgery containing one gram of calcium carbonate and 800IE 25(OH)D daily. At every 
follow-up all patients were requested to complete a paper form indicating which supplements 
they were taking. The brand of multivitamin taken was not recorded; however within Norway 
Nycoplus is the most common brand of vitamin and mineral supplement each tablet includes: 
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250 μg vitamin A, 10 μg vitamin D, 10 mg vitamin E, 120 μg vitamin K, 75 mg vitamin C, 
1,4 mg thiamin, 1,6 mg riboflavin, 19 mg Niacin, 1,5 mg vitamin B6,  200 μg folic acid, 2 μg 
vitamin B12, 30 μg biotin, 5 mg pantothenic acid, 100 mg magnesium, 15 mg iron, 12 mg 
zinc, 900 μg copper, 2,3 mg manganese, 60 μg selenium, 35 μg chromium, 150 μg iodine and 
45 μg molybdenum. 
Clinical and biological assessment 
To assess micronutrient status, blood was collected by venepuncture. The biochemical 
variables were analysed by the Department of Clinical Biochemistry at Førde Central Hospital 
except for the 25 (OH)D analyses (Hormone Laboratory, Haukeland University Hospital). All 
analyses were conducted through Architect CI8200, Abbott Diagnostics. 25(OH) D vitamin, 
ferritin, folate and vitamin B12 were detected in serum samples. Plasma and complete blood 
count were measured for PTH and haemoglobin. 25(OH) D vitamin, folate and vitamin B12 
were assayed by a competitive immunoassay using direct chemiluminescence technology.  
Statistical analyses  
All analyses were carried out using IBM® Statistical Package for the Social Sciences® 
(SPSS®) version 21. Values are expressed as mean ± SD. To examine micronutrient status of 
the patients at two different time points a paired sample t-test was performed. The repeated 
measure Anova was conducted to assess the effect of time (pre-operative, 12, 24 and 60 
months postoperatively). A p-value of less than 0.05 was used to declare statistical 
significance. 
RESULTS 
There were a maximum of 336 morbidly obese patients with preoperative and 1 year after 
surgery values, n=272 for 2 years and n=116 for 5 years after surgery. For the 336 morbidly 
obese patients studied (239 women and 97 men) the mean weight prior to LSG was 132.5 ± 
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23.9 kg (standard deviation (SD)), mean BMI 45.3 ± 6.2 kgm
-2
, and mean age 41.0 ± 11.7 
years (Table 1.). Mean (SD) change in BMI at 12 months was 15.2 ± 4.7 kgm
-2
 (n=322), 24 
months 15.3 ± 5.6 kg/m
2
 (n=267) and at 60 months mean change in BMI of 13.2 ± 6.0 kgm
-2
 
(n=107). We have follow-up data for weight in combination with an overview of 
micronutrient status from 322 patients at 12 months (96%), 267 patients at 24 months (98%) 
and 107 patients at 60 months (92%). The lower number of patients at 2 and 5 years reflects 
the total number who had their procedures at least 2 or 5 years before data collection. 
Very few patients were taking micronutrient supplements prior to surgery (Table 2.) After 
surgery the majority of patients were taking multivitamin supplements, dropping to 54% at 60 
months. Vitamin B12 supplementation was taken by 20-30% of patients at 12, 24 and 60 
months post-surgery. 
 
Micronutrient values prior to laparoscopic sleeve gastrectomy   
Prior to LSG 20.4% of patients had serum 25 (OH) D values below the reference range, 6.4% 
had serum vitamin B12 values below the reference range and 8.8% had serum folate values 
below the reference value (Table 3).  Preoperatively just 8 patients (2.4 %) of n=328 were 
anaemic, based on haemoglobin less than 11.5g/dl, and all were females. PTH values above 
reference was not found in any of the patients prior to surgery, nor post-surgery. 
Changes over time 
Ferritin serum levels were significantly lower at 12, 24 and 60 months compared with 
preoperative values (Table 4.) Those patients taking a multivitamin supplement at 60 months 
did have significantly higher ferritin levels compared with those not taking any micronutrient 
supplement (Table 6. p=0.003), patients taking iron supplements were excluded from the 
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analysis. Haemoglobin levels remain stable over time although levels were slightly lower at 
12 and 24 months compared with preoperative values (Table 4). 
Serum 25 (OH)D values at 12, 24 and 60 months were significantly greater compared with 
values prior to surgery (Table 4) and fewer patients had 25 (OH)D serum values below the 
reference range (Table 3). Those patients taking a multivitamin supplement at 12 months had 
significantly higher serum 25(OH) D values at 12 months postoperatively compared with 
those not taking a multivitamin supplement (p=0.032), though no differences at 60 months 
(Table 6). ALP and PTH were stable over time (Table 4). 
Serum folate values were also significantly greater at 12, 24 and 60 months compared with 
values prior to surgery (Table 4). Those patients taking a multivitamin supplement at 12 
months had significantly higher serum folate values at 12 months postoperatively compared 
with those not taking a multivitamin supplement (p=0.001) (Table 6).  
A larger proportion of patients had serum vitamin B12 values below the reference range at 12 
months (19 %) and 24 months (12.8%) compared with the 6.4% prior to surgery, though only 
3.8% were below the reference range at 60 months. The mean serum vitamin B12 value 
significantly decreased at 12months (Table 4).  
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Discussion  
LSG patients are potentially at risk of micronutrient deficiencies due to their substantially 
reduced dietary intake, decreased hydrochloric acid and intrinsic factor and possibly poor 
food choices. Therefore, it has been recommended for LSG patients to take daily 
micronutrient supplements to prevent any deficiencies (16). In the current study 75 and 70% 
of patients were taking multivitamin supplements 12 and 24 months’ post LSG respectively, 
this dropped to 54% at 5 years.  
Mean ferritin levels decreased over time, and prevalence of those below the reference ranges 
increased over time; similar to previous findings (8, 9, 12, 17).  The prevalence of low 
haemoglobin level 5 years after LSG was 5.2%. These findings are not supported by Saif et 
al. (2012) who reported 28.6% of patients (n=30) having a low haemoglobin level 5 years 
after LSG surgery(19). In the current study patients with a low ferritin or haemoglobin level 
after LSG may be explained by malabsorption and a reduction in hydrochloric acid that can 
potentially affect iron absorption (21, 22) or a restricted dietary iron intake. Aarts et al. (2011) 
found that a quarter of their patients had anemia, over 40 % had iron deficiency despite taking 
a multivitamin supplement(17). Serum ferritin is an acute phase reactant to inflammatory 
processes in obese individuals and in this way elevates the level of ferritin (23, 24). In this 
current study, seen in parallel with postoperative weight-loss, tissue inflammation may have 
reduced in patients and thereby also the ferritin levels at 1, 2 and 5 years post-surgery.  
Mean haemoglobin levels at 5 years were similar to preoperative values, similar to a large 
study by Aaseth et al. (2015) whereby there was no significant change in haemoglobin levels 
5 years after Roux-en-Y surgery compared to preoperative values (n=443)(25). 23.7% of the 
patients were taking iron supplementation 5 years’ post-surgery, where as in the current study 
only 12% were taking iron supplements. Serum ferritin values decreased even in those 
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patients taking multivitamin supplements, thus clinicians need to consider the value in 
screening patients to determine who may require iron supplementation. 
Intrinsic factor is necessary to release vitamin B12 contained in food; therefore, vitamin B12 
deficiencies could be expected with LSG. Deficiencies in vitamin B12 and iron have been 
noted at 1 year and 3 years post-LSG (7-9, 18). In our study at 12 and 24 months post-LSG a 
high proportion of patients (19% and 12.8%) had serum levels below the reference range; 
despite over 70% of patients taking one multivitamin tablet daily.  
Hakeam et al. (2009) reported the mean vitamin B12 concentration decreased significantly 12 
months post LSG with 26% of patients vitamin B12 deficient one year after LSG surgery(9). 
In addition, these patients were given five times the required daily allowance of oral vitamin 
B12 and this failed to prevent the postoperative deficiencies. This may indicate that B12 
deficiencies could be attributed to fundus resection after LSG, which can cause a reduction in 
IF and lead to B12 malabsorption. Gehrer et al. (2010) detected high B12 deficiencies in 
patients one year after LSG despite 10µg cyanocobalamin preoperative(10). However, the 
supplement with intramuscular cyanocobalamin corrected the deficiencies in 91% of the 
patients. This may indicate that early post-LSG, patients may be recommended to take B12 
supplementation in addition to intramuscular, to be effective. Saif et al. (2012) did not detect 
B12 deficiencies at 5 years (n=30), this is confirmed in our study whereby only 3.8 % had 
serum B12 values below the reference range (n=4/92).  
Only 12.3% of patients had folate values below the reference range 12 months after LSG, 
lower than the 12.5-28.6% reported previously among other LSG studies (7, 10, 17). Folate 
deficiency after LSG is not primarily caused by the surgery and the primary cause of this 
deficiency is more assigned to food choices and that folate stores decrease quickly when 
intake is insufficient (7, 17). 
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Serum vitamin D increased over time compared to levels prior to LSG surgery. This finding is 
supported by previous studies(7, 8, 11, 12, 19). This may be explained by several factors. 
Sixty-one patients were advised to take 800IE vitamin D3 daily postoperatively and every 
patient were advised to take one multivitamin tablet daily. In addition, Blum et al. (2008) 
showed a positive correlation between serum 25 (OH)D and adipose tissue in obese 
individuals indicating adipose tissue is a strong 25 (OH)D reservoir and thus storage release 
of 25 (OH)D due to significant weight loss 12 months post-operatively may explain the 
increase in mean serum 25 (OH)D values (26). 25 (OH)D values below the reference range  
improved postoperatively compared to preoperative values and the mean serum 25 (OH)D 
increased significantly at every time-point postoperatively.  
Previous studies have indicated that although patients after LSG are vitamin D deficient 
normal calcium status as evaluated by PTH and ALP levels are observed (7, 10, 12, 15, 17, 
19). The results from this study and supporting evidence from previous studies may indicate 
that calcium supplementation is not necessary as a routine in the long term, and might only be 
supplemented if deficiencies are detected (7, 8, 10, 12, 15, 17).  
Limitations 
This study has its limitations. It is hard to distinguish if the reduction of serum and plasma 
values below reference range were based on a lack of supplementation, weight loss or dietary 
intake. The compliance to multivitamin supplementation were not taken into account. In 
addition, it is not clear if patients were taking additional iron, vitamin B12 or folate 
supplementation apart from what was documented. Furthermore, the indication for initiating 
supplementation is not documented as this was started outside specialized care and we do not 
know whether this was based on serum values. As this study did not conduct a close monitor 
of patient’s type, quantity and frequency of vitamin and mineral intake it makes is hard to 
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establish if the multivitamin supplementation were inadequate or if the serum and plasma 
values below reference range are caused primarily by the LSG.  
Conclusion  
Most patients had values within the reference ranges for haemoglobin, vitamin B12, folate 
and vitamin D five years after LSG, while 36 % of the patients had serum ferritin below 
reference value.  
Ferritin levels decreased over time even with multivitamin supplementation. The vitamin B12 
level was lowest one year postoperatively while the vitamin D status was considerably 
improved at one year and remained stable thereafter. To improve micronutrient guidelines 
prior to and after LSG more research, including controlled supplementation studies are 
necessary.  
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Table 1. Sex, weight, body mass index and age of patients 
Variables Preoperative  
n/ mean       ±SD 
12m post-op 
n/ mean       ±SD 
24m post-op 
n/ mean       ±SD 
60m post-op 
n/ mean       ±SD 
Sex (women/men) 239/97  229/92  188/79  80/27  
Weight (kg)) 123.5 23.9 87.5 17.4 88.2 18.3 95.1 16.7 
BMI (kgm
-2
) 45.3 6.2 29.9 5.0 30.1 5.4 32.9 5.5 
Age (years) 41 11.7 41 11.7 41 11.5 41 11.0 
±SD=standard deviation; BMI=body mass index; m post-op. =months post-operative. 
 
 
 
 
 
Table 2. Percentage of patients reported to be consuming micronutrient supplements up to 60 
months after laparoscopic sleeve gastrectomy 
 
 
 
 
 
 
m post-op. =months post-operative. 
  
Supplements Preoperative 12m post-op 24m post-op 60m post-op 
  n 336 n 322 n 267 n 107 
Multivitamin 10.1 75.8 69.7 54.2 
Vitamin B12 3.6 21.4 23.6 29.9 
Folic Acid 1.2 3.4 7.9 12.1 
Calcium 0.9 12.7 19.5 26.2 
Vitamin D 1.2 3.7 3.0 3.7 
Iron 1.2 3.4 7.9 12.1 
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Table 3. Proportion of patients (%) with biochemical variables below or above reference 
values prior to and 12, 24 and 60 months after laparoscopic sleeve gastrectomy 
Variables with reference range preoperative 12m post-op 24m post-op 60m post-op 
 % n 270 n 288 n 219 n 90 
25 (OH)D vitamin deficient 20.4 4.9 8.2 6.7 
30-150 nmol/L normal 78.9 94.8 91.8 93.3 
 excess 0.7 0.3 - - 
Ferritin  n 334 n 301 n 230 n 94 
15-120 ug/L deficient 3.3* 11.6* 20* 36.2* 
 normal 60.5 55.8 57 57.4 
 excess 36.2 32.6 23 6.4 
Haemoglobin  n 336 n 308 n 242 n 97 
11.5-16.0 g/dl deficient 2.4 3.6 3.7 5.2 
 normal 93.8 92.2 91.7 92.8 
 excess 3.9 4.2 4.5 2.1 
Folate  n 328 n 308 n 236 n 94 
>6  nmol/L deficient 8.8 12.3 7.6 10.6 
 normal 91.2 87.7 92.2 89.4 
 excess - - - - 
Vitamin B12  n 329 n 306 n 234 n 92 
175-700 pmol/L deficient 6.4 19.0 12.8 3.8 
 normal 91.8 78.4 83.8 91.3 
 excess 1.8 2.6 3.4 5.4 
Results are expressed as percent %; m post-op. =months post-operative. * The percentage of females 
within the group preoperatively (100%), 12m (97%), 24m (98%) and 60m (91%). 25(OH)D = 25 
hydroxyvitamin D. Normal, deficient and excess levels are values based on analyses by the department 
of Clinical Biochemistry at Førde Central Hospital (except for 25 (OH)D) Hormone laboratory, 
Haukeland University Hospital. m post-op. =months post-operative. 
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Table 4. Micronutrient values comparing prior to surgery with 12, 24 and 60 months after 
laparoscopic sleeve gastrectomy 
 
 
 
Values expressed as mean ± standard deviation. Paired t test used to compare pre and post values. 
ALP=alkaline phosphatase; PTH=Parathyroid hormone  
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Table 5. Micronutrient values prior to and, 12, 24 and 60 months after laparoscopic sleeve 
gastrectomy 
Variables with 
reference ranges 
n 
preoperative 12m post-op 24m post-op 60m post-op 
25 (OH)D vitamin 
30-150 (nmol/L) 
59 43.4±21.7 
a,b
 60.2±25.2 58.7±20.1 62.8±23 
Parathyroid hormone 
0.7-7.5 (pmol/L) 
58 7.2±3.3c 7.2±2.6c 7.6±2.8 8.6±3.7 
Ferritin 
15-120 (ug/L) 
55 106±90.7 
b
 97.8±77.2 
b
 88.4±99.9 
b
 45.2±67.2 
Multivit at m60* 28 127±102 115±67 104±107 53±52 
No multivit* 20 101±68 97±58 75±52 26±20 
Haemoglobin 
11.5-16.0 (g/dl) 
71 13.6±1.2 13.3±1.1 13.5±1.1 13.7±1.2 
Folate 
>6 (nmol/L) 
67 12.6±6.0 17.3±10.6 20.2±11.9 18.4±11.5 
Vitamin B12 
175-700 (pmol/L) 
72 303±174 276±210 365±291 404±251 
Multivit at m60* 18 322±99 249±88 323±152 342±99 
No multivit* 15 354±170 250±130 304±147 374±243 
Results are expressed as mean ± SD and derived from repeated measures ANOVA. 
a
 significant 
difference with 24months, 
b
 significant difference to 60 months.* Excludes patients taking iron 
supplements at any time point; there was a significant difference over time, * Excludes patients taking 
vitamin B12 supplements at any time point; there was a significant difference over time. Multivit.= 
multivitamin and mineral supplement; m post-op. =months post-operative. 
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Table 6. Micronutrient values prior to, and at 12 and 60 months after laproscopic sleeve 
gastrectomy in those taking micronutrient supplements and those not. 
Vitamin supplement preoperative 12m post-op 60m post-op 
  N mean±SD N mean±SD N mean±SD 
25 (OH)D 
vitamin 
Multivitamin 28 56±16 221 63±22* 51 65±27 
Vitamin D 3 106±19 10 69±26 4 40±20 
  no supplement  242 47±25 52 55±26* 39 59±19 
Ferritin Multivitamin 33 101±76 233 114±113 51 60±71* 
  Ferritin 3 31±21 10 14±7 12 36±32 
  no supplement 301 121±110 53 87±76 43 27±23* 
Haemoglobin Multivitamin 34 14±1 238 14±2 52 14±1 
  Iron 4 13±2 10 13±1 12 13±2 
  no supplement  302 14±1 54 13±1 45 13±2 
Folate Multivitamin 32 21±11* 238 18±10* 51 19±11 
  Folate 3 32±7 15 24±15 4 36±5 
  no supplement  296 13±7* 54 13±10* 44 23±49 
Vitamin B 12 Multivitamin 32 338±164 240 291±186 52 377±251 
  Vitamin B12 11 291±100 67 377±295 27 495±341 
  no supplement  298 321±141 54 309±218 43 715±2084 
ALP Multivitamin 33 77±23 246 72.5 ± 22.1 52 70.5 ± 24.4 
  calcium 3 70.0 ± 8.9 41 70.0 ± 15.5 26 71.1 ± 23.3 
  no supplements 301 76±21 54 69.1 ± 17.1 43 67.5 ± 18.8 
PTH Multivitamin 29 6.9 ± 2.2 236 6.6 ± 2.7 52 9.5 ± 6.1 
  calcium 2 5.9 ± 0.9 38 7.3 ± 3.5 27 9.5 ± 4.9 
  no supplements 280 8.1 ± 4.5 52 7.3 ± 3.2 41 7.6 ± 3.7 
Biochemical variables are expressed as mean and ± standard diviation * significant difference between 
those taking a multivitamin supplement and those not (t test; P<0.05). Individual nutrient supplements 
were not included in statistical analysis due to small numbers. 
